MDB — Medicofarma Biotech SA Balance Sheet
0.000.00%
- PLN34.94m
- PLN34.92m
- PLN1.22m
Annual balance sheet for Medicofarma Biotech SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.064 | 0.077 | 0.508 | 0.005 | 0.006 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.149 | 1.44 | 0.583 | 0.38 | 0.632 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.387 | 2.08 | 2.26 | 2.52 | 3.81 |
| Net Property, Plant And Equipment | 0 | 12.7 | 12.6 | 12.1 | 10.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.396 | 16.8 | 16.4 | 15 | 14.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.625 | 0.522 | 3.28 | 4.02 | 4.49 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.625 | 2.56 | 3.76 | 5.8 | 7.84 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.229 | 14.2 | 12.6 | 9.18 | 6.87 |
| Total Liabilities & Shareholders' Equity | 0.396 | 16.8 | 16.4 | 15 | 14.7 |
| Total Common Shares Outstanding |